IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 205 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $43,350,109 | -29.8% | 4,501,569 | -22.4% | 0.04% | -27.9% |
| Q2 2023 | $61,717,458 | +13.4% | 5,800,513 | +12.2% | 0.06% | +10.9% |
| Q1 2023 | $54,405,957 | -15.6% | 5,171,669 | -0.6% | 0.06% | -19.1% |
| Q4 2022 | $64,436,710 | +34.0% | 5,200,703 | +12.0% | 0.07% | +25.9% |
| Q3 2022 | $48,101,000 | -5.6% | 4,642,905 | +5.0% | 0.05% | +1.9% |
| Q2 2022 | $50,979,000 | -9.2% | 4,421,528 | -1.0% | 0.05% | +10.4% |
| Q1 2022 | $56,170,000 | +4.1% | 4,465,048 | -3.5% | 0.05% | +65.5% |
| Q4 2021 | $53,947,000 | -11.2% | 4,626,583 | -0.5% | 0.03% | -12.1% |
| Q3 2021 | $60,741,000 | +16.4% | 4,650,891 | +14.7% | 0.03% | +17.9% |
| Q2 2021 | $52,201,000 | +25.9% | 4,056,047 | +9.4% | 0.03% | +33.3% |
| Q1 2021 | $41,454,000 | -5.0% | 3,707,830 | -3.2% | 0.02% | 0.0% |
| Q4 2020 | $43,639,000 | +32.6% | 3,831,351 | +4.7% | 0.02% | +5.0% |
| Q3 2020 | $32,911,000 | -13.9% | 3,658,958 | -1.2% | 0.02% | -25.9% |
| Q2 2020 | $38,202,000 | +10.5% | 3,701,689 | +8.1% | 0.03% | -10.0% |
| Q1 2020 | $34,566,000 | -15.2% | 3,425,758 | +11.8% | 0.03% | 0.0% |
| Q4 2019 | $40,770,000 | +43.6% | 3,063,143 | -7.4% | 0.03% | +25.0% |
| Q3 2019 | $28,390,000 | +35.0% | 3,306,922 | +72.1% | 0.02% | +26.3% |
| Q2 2019 | $21,026,000 | -2.7% | 1,921,917 | +20.3% | 0.02% | -5.0% |
| Q1 2019 | $21,611,000 | +31.1% | 1,597,203 | +0.4% | 0.02% | +17.6% |
| Q4 2018 | $16,480,000 | -35.2% | 1,590,801 | +15.4% | 0.02% | -26.1% |
| Q3 2018 | $25,450,000 | +1.3% | 1,378,664 | +4.9% | 0.02% | -8.0% |
| Q2 2018 | $25,133,000 | +5.3% | 1,314,550 | -15.0% | 0.02% | +13.6% |
| Q1 2018 | $23,877,000 | +1.4% | 1,547,413 | -1.5% | 0.02% | +4.8% |
| Q4 2017 | $23,539,000 | -4.9% | 1,570,283 | -0.0% | 0.02% | -12.5% |
| Q3 2017 | $24,764,000 | -2.4% | 1,570,328 | +16.9% | 0.02% | -4.0% |
| Q2 2017 | $25,368,000 | +1.7% | 1,343,576 | -8.1% | 0.02% | +13.6% |
| Q1 2017 | $24,950,000 | +4.7% | 1,462,453 | -6.2% | 0.02% | -8.3% |
| Q4 2016 | $23,828,000 | +1.3% | 1,558,428 | +5.2% | 0.02% | +9.1% |
| Q3 2016 | $23,515,000 | +13.4% | 1,480,763 | -6.6% | 0.02% | -4.3% |
| Q2 2016 | $20,735,000 | +19.9% | 1,585,867 | +0.3% | 0.02% | +9.5% |
| Q1 2016 | $17,298,000 | +2.1% | 1,581,186 | +8.2% | 0.02% | +10.5% |
| Q4 2015 | $16,937,000 | +12.9% | 1,461,380 | +1.5% | 0.02% | +5.6% |
| Q3 2015 | $14,998,000 | -14.0% | 1,439,314 | -0.4% | 0.02% | +5.9% |
| Q2 2015 | $17,433,000 | +871.2% | 1,445,577 | +1188.3% | 0.02% | +750.0% |
| Q1 2015 | $1,795,000 | +0.6% | 112,210 | -3.7% | 0.00% | 0.0% |
| Q4 2014 | $1,784,000 | +106.0% | 116,484 | +74.3% | 0.00% | +100.0% |
| Q3 2014 | $866,000 | -91.4% | 66,843 | -89.8% | 0.00% | -87.5% |
| Q2 2014 | $10,075,000 | +630.6% | 657,195 | +487.6% | 0.01% | +700.0% |
| Q1 2014 | $1,379,000 | -7.3% | 111,843 | -12.7% | 0.00% | 0.0% |
| Q4 2013 | $1,487,000 | +86.3% | 128,041 | +90.1% | 0.00% | 0.0% |
| Q3 2013 | $798,000 | -25.0% | 67,344 | -37.1% | 0.00% | 0.0% |
| Q2 2013 | $1,064,000 | -2.3% | 107,149 | +79.9% | 0.00% | 0.0% |
| Q1 2013 | $1,089,000 | – | 59,560 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 1,520,000 | $19,562,000 | 18.54% |
| Sarissa Capital Management LP | 16,390,000 | $210,939,000 | 16.77% |
| Healthcare Value Capital, LLC | 200,000 | $2,574,000 | 5.13% |
| Camber Capital Management LP | 7,500,000 | $96,525,000 | 3.25% |
| 13D Management LLC | 650,455 | $8,371,000 | 2.88% |
| BRIDGER MANAGEMENT, LLC | 2,035,114 | $26,192,000 | 2.44% |
| Brown Capital Management | 18,484,759 | $237,899,000 | 1.80% |
| Healthcare Value Capital, LLC | 50,000 | $644,000 | 1.28% |
| Zebra Capital Management LLC | 53,359 | $687,000 | 0.80% |
| PRICE MICHAEL F | 520,000 | $6,692,000 | 0.74% |